Gaining the accreditation equips the Laboratory Services Division (LSD) to determine the quality of anti-tuberculosis drugs. “This is a milestone not only for the FDA, but for the people of the Philippines and the surrounding region”, said Maria Lourdes Santiago, chief LSD.
Support for the LSD was provided by the US Agency for International Development (USAID) and the Promoting the Quality of Medicines (PQM) programme. PQM is implemented by the US Pharmacopeial Convention (USP).